BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

FHLCvsRSPHETF Comparison

ETF 1

FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of

US Health Care

+0.14%

Full FHLC fund page

VS

ETF 2

RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of

US Health Care

+0.14%

Full RSPH fund page

Fidelity MSCI Health Care Index ETF (FHLC) and Invesco S&P 500® Equal Weight Health Care ETF (RSPH) belong to the same industry segment: US Health Care. FHLC's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, RSPH's top sector exposures are Healthcare and Consumer Non-Cyclicals. FHLC is less expensive with a Total Expense Ratio (TER) of 0.084%, versus 0.4% for RSPH. FHLC is up 16.94% year-to-date (YTD) with +$478M in YTD flows. RSPH performs better with 24.56% YTD performance, and +$60M in YTD flows. Run a side-by-side ETF comparison of FHLC and RSPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

FHLC vs RSPH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/26/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	FHLC RSPH	+3.76%+5.33%	+8.83%+15.82%	+16.94%+24.56%	+23.63%+28.65%	+53.42%+56.64%	+39.86%+33.25%
Flows	FHLC RSPH	+$77M+$50M	+$226M+$103M	+$478M+$60M	+$542M+$56M	-$184M-$224M	+$18M-$210M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	FHLC RSPH	+17.04%+18.94%	+15.91%+16.82%	+14.92%+15.93%	+15.51%+16.80%
Max drawdown	FHLC RSPH	-5.64%-5.57%	-10.35%-10.87%	-16.88%-16.96%	-17.78%-21.91%
Max drawdown duration	FHLC RSPH	56d55d	169d116d	435d434d	762d817d

Trading data

Create an account to view trading data

Join for free

	FHLC	RSPH
Last sale 10/27/2026 at 1:30 PM	$86.08	$39.35
Previous close 10/26/2026	$86.00	$39.46
Consolidated volume 10/26/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	FHLC	RSPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/27/2026 at 1:30 PM

Live

Closed

	FHLC	RSPH
Last price	$86.08	$39.35
1D performance	+0.09%	-0.28%
AuM	$3.82 B	$976.29 M
E/R	0.084%	0.4%

Characteristics

	FHLC	RSPH
Management strategy	Passive	Passive
Provider	Fidelity	Invesco
Benchmark	MSCI USA IMI Health Care 25/50 Index	S&P 500 Equal Weight Health Care Index
N° of holdings	338	59
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	October 21, 2013	November 1, 2006
ESG	No	No

More FHLC data on Trackinsight

More RSPH data on Trackinsight

Exposure

Countries

FHLC

USA

97.14%

Other

2.86%

RSPH

USA

96.79%

Other

3.21%

Sectors

FHLC

Healthcare

98.23%

Other

1.77%

RSPH

Healthcare

98.64%

Other

1.36%

Diversification

FHLC

Total weight of top 15 holdings out of 15

60.85%

RSPH

Total weight of top 15 holdings out of 15

31.58%

Top 15 holdings

Data as of August 31, 2026

FHLC

Eli Lilly & Co.

12.94%

Johnson & Johnson

8.88%

AbbVie, Inc.

6.21%

Merck & Co., Inc.

5.04%

UnitedHealth Group, Inc.

4.91%

Amgen, Inc.

3.21%

Thermo Fisher Scientific, Inc.

3.19%

Abbott Laboratories

2.69%

Gilead Sciences, Inc.

2.49%

Pfizer Inc.

2.19%

Vertex Pharmaceuticals, Inc.

1.90%

Danaher Corp.

1.89%

Bristol Myers Squibb Co.

1.87%

Intuitive Surgical, Inc.

1.82%

CVS Health Corp.

1.63%

RSPH

Moderna, Inc.

4.45%

Veeva Systems, Inc.

2.47%

Charles River Laboratories International, Inc.

2.28%

IQVIA Holdings, Inc.

2.07%

Bio-Techne Corp.

1.98%

Regeneron Pharmaceuticals, Inc.

1.92%

Thermo Fisher Scientific, Inc.

1.88%

Amgen, Inc.

1.85%

Revvity, Inc.

1.83%

Baxter International, Inc.

1.83%

Becton, Dickinson & Co.

1.82%

Vertex Pharmaceuticals, Inc.

1.80%

Merck & Co., Inc.

1.80%

Abbott Laboratories

1.79%

Labcorp Holdings, Inc.

1.79%

Frequently asked questions about FHLC and RSPH

How have the FHLC and RSPH ETFs performed in 2026?

As of October 26, 2026, FHLC is up 16.94% year-to-date (YTD), while RSPH has returned 24.56%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: FHLC or RSPH?

Year-to-date, the FHLC ETF saw +$478M in flows, compared to +$60M for RSPH.

Which ETF is more volatile: FHLC or RSPH?

Over the past year, FHLC had a volatility of 15.91%, while RSPH experienced 16.82%.

Which ETF is bigger: FHLC or RSPH?

As of October 26, 2026, FHLC holds $3.82 B in assets under management (AUM), while RSPH manages $976.29 M.

What sectors do the FHLC and RSPH ETFs invest in?

FHLC leans toward sectors like Healthcare. Meanwhile, RSPH focuses on Healthcare.

What are the top holdings of the FHLC ETF and RSPH ETF?

FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. RSPH holds in its top three: Moderna, Inc., Veeva Systems, Inc. and Charles River Laboratories International, Inc..

Which ETF is more diversified: FHLC or RSPH?

FHLC holds 338 securities with 60.85% of its assets in the top 15. RSPH has 59 securities and a top 15 weight of 31.58%.

Tony's ETF Buyers Guide: Equal-Weight ETFs

May 14, 2024

RSPH

FHLCvsRSPHETF Comparison

Fidelity MSCI Health Care Index ETF

Invesco S&P 500® Equal Weight Health Care ETF

FHLC vs RSPH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the FHLC and RSPH ETFs performed in 2026?

As of October 26, 2026, FHLC is up 16.94% year-to-date (YTD), while RSPH has returned 24.56%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: FHLC or RSPH?

Year-to-date, the FHLC ETF saw +$478M in flows, compared to +$60M for RSPH.

Which ETF is more volatile: FHLC or RSPH?

Over the past year, FHLC had a volatility of 15.91%, while RSPH experienced 16.82%.

Which ETF is bigger: FHLC or RSPH?

As of October 26, 2026, FHLC holds $3.82 B in assets under management (AUM), while RSPH manages $976.29 M.

What sectors do the FHLC and RSPH ETFs invest in?

FHLC leans toward sectors like Healthcare. Meanwhile, RSPH focuses on Healthcare.

What are the top holdings of the FHLC ETF and RSPH ETF?

FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. RSPH holds in its top three: Moderna, Inc., Veeva Systems, Inc. and Charles River Laboratories International, Inc..

Which ETF is more diversified: FHLC or RSPH?

FHLC holds 338 securities with 60.85% of its assets in the top 15. RSPH has 59 securities and a top 15 weight of 31.58%.

Tony's ETF Buyers Guide: Equal-Weight ETFs

ETFs’ Next Act: From Access to Selection